Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Contact Information
Affiliated Doctors
The name “Memorial Sloan-Kettering” is virtually synonymous with premier cancer care. Located in New York City, this prestigious cancer center offers a team approach to provide exceptional care for patients diagnosed with mesothelioma and other forms of cancer. It combines state-of-the-art research and equipment, educational programs, comprehensive treatment options and a variety of complementary support services in order to improve patients' prognosis and quality of life.
Memorial Sloan-Kettering Cancer Center, also known as MSKCC, is the world's largest and oldest private cancer center. It has a number of facilities throughout Manhattan and the tris-state area, providing diagnosis, inpatient and outpatient services, and ambulatory care. MSKCC also offers training programs for those interested in the biomedical sciences, both physicians and scientists, in collaboration with several prestigious colleges and universities.
Additionally, research at Sloan-Kettering Institute helps expand the knowledge base in areas such as cell biology, molecular biology, structural biology, biochemistry, genetics, immunology and therapeutics. This, in turn, allows physicians at the cancer center to improve their treatment approaches in order to better serve patients. More effective cancer diagnosis and treatment methods are also investigated through the clinical trials offered by Memorial Sloan-Kettering. Currently, the number of trials offered tops 400.
The oncologists and other medical professionals at Memorial Sloan-Kettering are experts in their respective fields, and up-to-date on the latest innovations in treatment protocols. Each patient at MSKCC will be treated by a team of health care workers, including medical oncologists, radiation oncologists, surgeons, pathologists, nurses, psychiatrists, nutritionists and social workers. The Disease Management Program at the cancer center has 16 multidisciplinary teams, each made up of specialists who are not only highly skilled and experienced, but also compassionate and patient-centered.
Memorial Sloan-Kettering offers mesothelioma patients an interdisciplinary Pain and Palliative Care Service, as well as an Integrative Medicine Service devoted to the exploration of complementary therapies such as hypnotherapy, massage therapy and acupuncture.
The surgeons at Memorial Sloan-Kettering perform more operations on cancer patients than any other hospital in the country. MSKCC is also one of only 40 National Cancer Institute-designated Comprehensive Cancer Centers. To receive this designation, the cancer center must demonstrate “reasonable depth and breadth of research activities in each of three main areas: laboratory, clinical and population-based research, with substantial transdisciplinary research that bridges these scientific areas” and “must also demonstrate professional and public education and dissemination of clinical and public health advances into the the community it serves.”
Currently, MSKCC is conducting three ongoing Phase II studies, and one Phase III study, which malignant pleural mesothelioma patients may enter into. Some of the renowned and well-respected physicians who specialize in mesothelioma treatment and research at Memorial Sloan-Kettering include Dr. Lee M. Krug; Dr. David H. Ilson, and Dr. Valerie W. Rusch. Countless other mesothelioma specialists have either interned or completed residencies at Memorial Sloan-Kettering. The cancer center's list of constributions to the field of mesothelioma research and treatment is extensive, both in research and in patient-centered treatment.